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Administrative Bulletin 17-05 
 
101 CMR 320.00 Clinical Laboratory Services 
 
Effective January 1, 2017 
 
Procedure Code Update  
 
Under the authority of regulation 101 CMR 320.01(3), the Executive Office of Health and Human 
Services is adding new procedure codes and deleting outdated codes.  The rates for code additions are 
priced at 74.67% of the prevailing Medicare fee if available.  The rate for new code replacements was 
set at the rate previously set for the replaced codes.  The changes, effective January 1, 2017, are as 
follows:  
 
Code Change Rate Code Description (if applicable) 
80305 Addition $8.92 Drug tests(s), presumptive, any number of drug classes, any 
number of devices or procedures (eg, immunoassay); capable 
of being read by direct optical observation only (eg, dipsticks, 
cups, cards, cartridges) includes sample validation when 
performed, per date of service 
80306 Addition $11.89 Drug test(s), presumptive, any number of drug classes, any 
number of devices or procedures, (eg, immunoassay) read by 
instrument assisted direct optical observation (eg, dipsticks, 
cups, cards, cartridges), includes sample validation when 
performed, per date of service 
80307 Addition $47.55 Drug test(s), presumptive, any number of drug classes, any 
number of devices or procedures, by instrument chemistry 
analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, 
EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, 
HPLC), and mass spectrometry either with or without 
chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, 
LC-MS, LCMS/MS, LDTD, MALDI, TOF) includes sample 
validation when performed, per date of service 
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Code Change Rate Code Description (if applicable) 
81280 Discontinued   
81281 Discontinued   
81282 Discontinued   
81327 Addition $62.48 SEPT9 (Septin9) (eg, colorectal cancer) methylation analysis 
81413 Addition $599.10 Cardiac ion channelopathies (eg, Brugada syndrome, long QT 
syndrome, short QT syndrome, catecholaminergic 
polymorphic ventricular tachycardia); genomic sequence 
analysis panel, must include sequencing of at least 10 genes, 
including ANK2, CASQ2, CAV3, KCNE1, KCNE2, KCNH2, 
KCNJ2, KCNQ1, RYR2, and SCN5A 
81414 Addition $599.10 Cardiac ion channelopathies (eg, Brugada syndrome, long QT 
syndrome, short QT syndrome, catecholaminergic 
polymorphic ventricular tachycardia); duplication/deletion 
gene analysis panel, must include analysis of at least 2 genes, 
including KCNH2 and KCNQ1 
81422 Addition $599.10 Fetal chromosomal microdeletion(s) genomic sequence 
analysis (eg, DiGeorge syndrome, Cri-du-chat syndrome), 
circulating cell-free fetal DNA in maternal blood 
81439 Addition $599.10 Inherited cardiomyopathy (eg, hypertrophic cardiomyopathy, 
dilated cardiomyopathy, arrhythmogenic right ventricular 
cardiomyopathy) genomic sequence analysis panel, must 
include sequencing of at least 5 genes, including DSG2, 
MYBPC3, MYH7, PKP2, and TTN 
81539 Addition $449.59 Oncology (high-grade prostate cancer), biochemical assay of 
four proteins (Total PSA, Free PSA, Intact PSA and human 
kallikrein-2 [hK2]), utilizing plasma or serum, prognostic 
algorithm reported as a probability score 
84410 Addition $54.17 Testosterone; bioavailable, direct measurement (eg, 
differential precipitation) 
87483 Addition $217.81 Infectious agent detection by nucleic acid (DNA or RNA); 
central nervous system pathogen (eg, Neisseria meningitidis, 
Streptococcus pneumoniae, Listeria, Haemophilus influenzae, 
E. coli, Streptococcus agalactiae, enterovirus, human 
parechovirus, herpes simplex virus type 1 and 2, human 
herpes virus 6, cytomegalovirus, varicella zoster virus, 
Cryptococcus), includes multiplex reverse transcription, 
when performed, and multiplex amplified probe technique, 
multiple types or subtypes, 12-25 targets 
 
Crosswalks 
 
Deleted Codes Replacement Codes 
G0477 80305 
G0478 80306 
G0479 80307 
 
 
